Robotic Rehabilitation for Stroke Survivors

December 6, 2023 updated by: Amit Kandel, MD, MBA, State University of New York at Buffalo
Pilot study on the physiological response of robotic rehabilitation therapy for improving the performance of activities of daily living of stroke patients

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The purpose of this research is to study the feasibility of the robotic therapy that can train activities of daily living tasks for chronic stroke patients. The participant will be involved in a feasibility study (one-time visit) to prove the efficacy of the robotic device with different force feedback (assistive and resistive force) and other feedback such as VR (virtual reality). We will collect movement data from a motion capture system and sEMG sensors that measure muscle activity to monitor the effect of a robotic rehabilitation device, named Spherical Parallel Instrument for Daily Living Emulation (SPINDLE). We will use a robotic therapy device to practice activities during daily living. This pilot study will be used to understand the effect of SPINDLE to translate the device as a home-based training for chronic stroke patients.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • Buffalo, New York, United States, 14260
        • University at Buffalo, North Campus, Furnas 809
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study participant needs to have minimal strength to move the robot. The participant needs to be able to understand the instructions during the experiment.

Description

Inclusion Criteria:

  • Adults with chronic stroke, which affected their upper limb motor functions
  • Adults could able to understand the verbal cues during the training

Exclusion Criteria:

  • Adults with chronic stroke, who did not lose their upper limb motor functions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participant with Chronic stroke
  1. Participants over 18 years of age
  2. Participants should be able to understand the verbal cues during the training
SPINDLE will provide an assistive and resistive force to aid in rehabilitating the subject's upper limb

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinematic change of the upper limb during ADLs
Time Frame: immediately after the intervention
The max and range of motion of shoulder, elbow, and wrist joint for each task
immediately after the intervention
Score of activities of daily living(ADL) tasks
Time Frame: immediately after the intervention
We will use ARM-ULA standard score sheet to measure the performance of ADLs
immediately after the intervention
Muscle activation change of the upper limb during ADLs
Time Frame: immediately after the intervention
The subject will be asked to perform activities of daily living tasks with the passive SPINDLE. Upper limb range of motion and muscle activation will be quantified.
immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability measure
Time Frame: immediately after the intervention
Questionnaire will be provided to the user to obtain qualitative feedback
immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jiyeon Kang, University at Buffalo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2024

Primary Completion (Estimated)

December 5, 2024

Study Completion (Estimated)

December 5, 2024

Study Registration Dates

First Submitted

June 5, 2022

First Submitted That Met QC Criteria

June 8, 2022

First Posted (Actual)

June 14, 2022

Study Record Updates

Last Update Posted (Estimated)

December 13, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The de-identified data will be shared upon request to PI.

IPD Sharing Time Frame

After the study is completed

IPD Sharing Access Criteria

The personnel who is requesting the data needs to explain how the data will be used in their research.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Stroke

3
Subscribe